- Home
- HROW vs IMKTA Comparison
HROW vs IMKTA Comparison
Compare HROW & IMKTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HROW
- IMKTA
- Stock Information
- Founded
- HROW 1998
- IMKTA 1963
- Country
- HROW United States
- IMKTA United States
- Employees
- HROW N/A
- IMKTA N/A
- Industry
- HROW Biotechnology: Pharmaceutical Preparations
- IMKTA Food Chains
- Sector
- HROW Health Care
- IMKTA Consumer Staples
- Exchange
- HROW Nasdaq
- IMKTA Nasdaq
- Market Cap
- HROW 1.4B
- IMKTA 1.3B
- IPO Year
- HROW N/A
- IMKTA N/A
- Fundamental
- Price
- HROW $36.81
- IMKTA $68.59
- Analyst Decision
- HROW Strong Buy
- IMKTA
- Analyst Count
- HROW 7
- IMKTA 0
- Target Price
- HROW $68.50
- IMKTA N/A
- AVG Volume (30 Days)
- HROW 804.0K
- IMKTA 83.7K
- Earning Date
- HROW 11-10-2025
- IMKTA 08-07-2025
- Dividend Yield
- HROW N/A
- IMKTA 0.95%
- EPS Growth
- HROW N/A
- IMKTA N/A
- EPS
- HROW N/A
- IMKTA 2.97
- Revenue
- HROW $227,661,000.00
- IMKTA $5,363,138,171.00
- Revenue This Year
- HROW $43.92
- IMKTA N/A
- Revenue Next Year
- HROW $41.22
- IMKTA N/A
- P/E Ratio
- HROW N/A
- IMKTA $23.38
- Revenue Growth
- HROW 47.69
- IMKTA N/A
- 52 Week Low
- HROW $20.85
- IMKTA $58.92
- 52 Week High
- HROW $54.19
- IMKTA $75.63
- Technical
- Relative Strength Index (RSI)
- HROW 38.13
- IMKTA 38.70
- Support Level
- HROW $36.20
- IMKTA $68.54
- Resistance Level
- HROW $39.77
- IMKTA $72.97
- Average True Range (ATR)
- HROW 1.89
- IMKTA 1.76
- MACD
- HROW -0.40
- IMKTA -0.62
- Stochastic Oscillator
- HROW 9.98
- IMKTA 0.75
About HROW Harrow Inc.
Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans. Its operating segments are The Branded segment includes activities of the Company's FDA-approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain of branded products; and The ImprimisRx segment represents activities in the Company's ophthalmology-focused pharmaceutical compounding business.
About IMKTA Ingles Markets Incorporated
Ingles Markets Inc is a U.S.-based company that is principally engaged in operating a supermarket chain. The company operates the business in the southeast United States, mainly in Georgia, North Carolina, South Carolina, and Tennessee, with a few stores in Virginia and Alabama as well. The company locates its stores majorly in suburban areas, small towns, and neighborhood areas. It offers a broad range of goods, including food products, pharmacies, health and beauty care products, and general merchandise. The retail business contributes the majority of the company's revenue. The company's real estate ownership of a material portion of total stores enables it to generate rental income.